Abstract

Diclofenac Sodium 10-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2011 - Volume 15, Number 1

Page(s): 64

Download in electronic PDF format for $75

Abstract

A formulation for preparing Diclofenac Sodium 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2011 Pg. 64	Diclofenac Sodium 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 421	Diclofenac Sodium 75-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 65	Diclofenac Sodium 1% Soft-Patch Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 74	Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 134	Diclofenac Sodium 1% Soft-patch Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 243	Diclofenac Sodium 1% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 66	Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Nov/Dec 1999 Pg. 496-500	Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Author(s): Goodwin Donald A, Fuhram L Clifton
Mar/Apr 2006 Pg. 154-155	Chemical Stability of Diclofenac Sodium Injection Author(s): Gupta Vishnu D
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 167-174	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso